If steroid injections haven’t provided lasting relief for your chronic back or neck pain, the underlying disc structure may be the issue — not just inflammation. Regenerative options like intra-annular fibrin injection target disc damage directly. Candidates are evaluated individually; outcomes vary, but many patients experience meaningful, longer-lasting relief than injections alone provide.

Why Injections Often Provide Only Temporary Relief

Epidural steroid injections are a common first-line treatment for spine-related pain. By reducing inflammation around irritated nerves, they can offer a window of relief — and for some patients, that window is enough to complete physical therapy and strengthen supporting structures. For many others, however, the benefit is short-lived.

The core limitation is that steroid injections are anti-inflammatory, not restorative. They don’t repair damaged tissue. A systematic review by the American Academy of Family Physicians found that epidural steroid injections are not effective for chronic low back pain over the long term — consistent with what many patients experience: a few weeks or months of reduced discomfort, followed by a return of symptoms at similar or greater intensity.

This cycle can be both emotionally and physically draining. It may also delay proper diagnosis of the underlying structural problem, allowing disc damage to progress. If pain has persisted through multiple rounds of injections, that’s a signal worth taking seriously — and a reason to evaluate whether the root cause is being addressed at all.

Understanding the Root Cause: Disc Damage and Annular Tears

For many people with chronic back or neck pain, the source isn’t inflammation alone — it’s structural damage within the spinal discs themselves. Each disc has a tough outer layer (the annulus fibrosus) and a gel-like center (the nucleus pulposus). Over time, due to aging, repetitive stress, injury, or genetic factors, the annulus can develop small tears.

These annular tears may appear minor on imaging, but they can be a significant source of discogenic pain. When the nucleus pulposus leaks through a tear, it can irritate surrounding nerves and trigger a chronic inflammatory response. Over time, this leakage may also weaken the disc, contributing to bulging or herniation and symptoms such as leg pain from nerve compression.

Standard MRI imaging sometimes misses subtle annular tears, leading to vague diagnoses like “non-specific back pain.” When the structural damage isn’t identified and addressed, treatments that only reduce inflammation or strengthen surrounding muscles tend to offer limited, temporary benefit — which is why some patients find themselves cycling through the same interventions without durable relief.

When Conservative Treatments Fall Short

Physical therapy, chiropractic care, and over-the-counter medications serve an important role in spine care. For patients with acute injuries or less severe conditions, these approaches can support meaningful recovery. The body has a significant capacity for self-healing, and conservative care helps many patients — particularly those with sciatica, where a substantial portion of cases resolve without surgery.

When persistent pain doesn’t respond to consistent conservative care, it may indicate that the underlying pathology requires a different approach. For patients who have exhausted conventional options and are still dealing with debilitating pain, the next step is often framed as spinal surgery — but that option carries real considerations worth weighing carefully.

A significant percentage of back surgeries do not achieve the desired outcome, and a condition known as Failed Back Surgery Syndrome affects patients whose pain persists or worsens after spinal procedures. Many patients facing a surgery recommendation choose to explore alternatives before proceeding — and regenerative medicine has expanded what those alternatives look like.

The Promise of Regenerative Medicine for Disc Repair

Regenerative medicine takes a fundamentally different approach: rather than masking pain or surgically altering spinal anatomy, it aims to support the body’s own healing processes and address the structural source of pain directly.

Platelet-Rich Plasma (PRP) therapy is one well-known regenerative option, using concentrated growth factors from a patient’s own blood to stimulate healing in injured tissue. For conditions involving annular tears and discogenic pain specifically, a more targeted biologic approach has emerged: intra-annular fibrin injection.

This fibrin disc treatment is designed to address the structural damage that injections and physical therapy cannot reach — the torn annular fibers themselves. By focusing on repair rather than symptom suppression, it offers a different pathway for patients who haven’t responded to conventional care.

Intra-Annular Fibrin Injection: How Biologic Disc Repair Works

Intra-annular fibrin injection — also referred to as biologic disc repair or fibrin disc treatment — is a minimally invasive procedure that addresses damaged discs and annular tears directly. Unlike steroid injections, which temporarily reduce inflammation, or spinal fusion, which eliminates motion at a vertebral segment, this treatment targets the structural integrity of the disc itself.

A fibrin sealant derived from fibrinogen and thrombin — proteins involved in the body’s natural clotting and wound-healing processes — is precisely injected into the affected disc under imaging guidance. The fibrin seals the annular tears, limiting the leakage of disc material that irritates surrounding nerves. It also acts as a biological scaffold, creating an environment that may support the regeneration of disc tissue over time.

Expert Take

Fibrin is not a foreign substance — it’s a protein the body uses in natural wound repair. When delivered to damaged disc tissue under imaging guidance, it may help initiate a healing response that neither anti-inflammatory injections nor surgical removal of disc material can provide. Candidacy requires individual evaluation; not everyone with annular tears is an appropriate candidate, and recovery experiences vary considerably.

Published research on this approach has shown encouraging results. In clinical studies, patients treated with intra-annular fibrin injection demonstrated meaningful reductions in pain scores — from a baseline of 72.4mm to 33.0mm on the Visual Analog Scale at 104 weeks (over two years). A 70% patient satisfaction rate was reported at the two-plus year follow-up in these studies. Among patients who had previously undergone back surgery and continued to experience pain, approximately 80% in published study populations reported positive outcomes — suggesting potential benefit even in complex, post-surgical cases. These figures reflect study populations and research findings; individual outcomes vary and cannot be guaranteed.

Compared to spinal fusion — which typically involves a recovery period of three to six months or longer and carries risks of revision surgery and adjacent segment disease — biologic disc repair is performed on an outpatient basis with significantly less downtime. It also preserves spinal motion, which fusion does not.

Who May Be a Candidate for Regenerative Spine Care

Candidacy for fibrin disc treatment is determined through individual evaluation. Patients who may be appropriate candidates are often those who:

• Have had chronic back or neck pain lasting longer than six months
• Have a diagnosis consistent with discogenic pain — including degenerative disc disease, annular tears, or contained disc herniation
• Have not achieved lasting relief from physical therapy, chiropractic care, or steroid injections
• Are seeking to avoid spinal surgery, or have already undergone surgery and continue to experience pain
• Are in adequate overall health, without active infection or conditions that would contraindicate the procedure

MRI imaging provides a starting point, but subtle annular tears are sometimes missed on standard scans. In some cases, a specialized diagnostic procedure called provocative discography is used to confirm the painful disc level and ensure treatment is precisely targeted to the source of pain.

Our clinical team conducts a thorough review of each patient’s history, imaging, and physical examination before making any recommendations. Treatment is recommended only when the evidence supports it as the most appropriate option for that individual’s specific condition. No two spines or pain histories are identical, and our evaluation process reflects that.

Our Approach to Non-Surgical Spine Care

At ValorSpine, we focus on non-surgical spine solutions that address the underlying source of pain — not just the symptoms. We use advanced imaging guidance for all injection procedures and maintain a conservative standard for candidacy: treatment is recommended only when it aligns with the patient’s specific diagnosis and clinical picture.

Our clinical team has deep experience in interventional pain management and regenerative medicine. We regularly see patients who have been through multiple rounds of injections, extended physical therapy, and in some cases prior surgery. We take a structured, evidence-based approach to evaluating what is actually driving chronic pain — and we’re direct about what we believe treatment can and cannot accomplish for a given case.

For patients who have been told spinal fusion is their only remaining option, a second opinion and full evaluation of spinal fusion alternatives is always worth pursuing before committing to surgery. Many patients who did not respond to conventional care have experienced meaningful relief through biologic disc repair. Outcomes vary by individual, and we are committed to honest, individualized guidance at every step.

For more on how disc damage drives chronic pain, see: Annular Tears: A Root Cause of Back Pain and the Role of Annular Tear Repair